| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Marquez SB, Thompson KW, Lu L, Reisman D. Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation. Frontiers in Oncology. 4: 372. PMID 25774356 DOI: 10.3389/fonc.2014.00372 |
0.095 |
|
| 2015 |
Thompson KW, Marquez SB, Lu L, Reisman D. Induction of functional Brm protein from Brm knockout mice. Oncoscience. 2: 349-61. PMID 26097869 DOI: 10.18632/oncoscience.153 |
0.071 |
|
| 2014 |
Kahali B, Gramling SJ, Marquez SB, Thompson K, Lu L, Reisman D. Identifying targets for the restoration and reactivation of BRM. Oncogene. 33: 653-64. PMID 23524580 DOI: 10.1038/onc.2012.613 |
0.039 |
|
| 2010 |
Chow TW, Varpetian A, Moss T, Vinters HV, Marquez S, Miller C. Alzheimer's disease neuropathologic changes in semantic dementia. Neurocase. 16: 15-22. PMID 19866390 DOI: 10.1080/13554790903193174 |
0.034 |
|
| 2014 |
Kahali B, Marquez SB, Thompson KW, Yu J, Gramling SJ, Lu L, Aponick A, Reisman D. Flavonoids from each of the six structural groups reactivate BRM, a possible cofactor for the anticancer effects of flavonoids. Carcinogenesis. 35: 2183-93. PMID 24876151 DOI: 10.1093/carcin/bgu117 |
0.033 |
|
| 2014 |
Kahali B, Yu J, Marquez SB, Thompson KW, Liang SY, Lu L, Reisman D. The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors. Oncotarget. 5: 3316-32. PMID 24913006 DOI: 10.18632/Oncotarget.1945 |
0.025 |
|
| 2014 |
Thompson KW, Marquez SB, Reisman D. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1--letter. Cancer Research. 74: 4946-7. PMID 25136073 DOI: 10.1158/0008-5472.CAN-13-2457 |
0.01 |
|
| Hide low-probability matches. |